Myron Kaplan - 22 Feb 2022 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Director
Signature
/s/ Myron Kaplan
Issuer symbol
CRMD
Transactions as of
22 Feb 2022
Net transactions value
$0
Form type
4
Filing time
23 Feb 2022, 15:16:04 UTC
Previous filing
29 Dec 2021
Next filing
18 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CRMD Common Stock 155,034 22 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy Common Stock) Award $0 +20,000 $0.000000 20,000 22 Feb 2022 Common Stock 20,000 $4.03 Direct F7
holding CRMD Stock Option (Right to Buy Common Stock) 30,000 22 Feb 2022 Common Stock 30,000 $8.32 Direct F1
holding CRMD Stock Option (Right to Buy Common Stock) 15,000 22 Feb 2022 Common Stock 15,000 $5.63 Direct F2
holding CRMD Stock Option (Right to Buy Common Stock) 15,000 22 Feb 2022 Common Stock 15,000 $8.30 Direct F3
holding CRMD Stock Option (Right to Buy Common Stock) 8,000 22 Feb 2022 Common Stock 8,000 $2.85 Direct F4
holding CRMD Stock Option (Right to Buy Common Stock) 8,000 22 Feb 2022 Common Stock 8,000 $11.20 Direct F5
holding CRMD Stock Option (Right to Buy Common Stock) 10,000 22 Feb 2022 Common Stock 10,000 $21.40 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted on 1/11/2021. These options are fully vested.
F2 These options were granted on 02/25/2020. These options are fully vested.
F3 These options were granted on 01/10/2019. These options are fully vested.
F4 These options were granted on 02/16/2018. These options are fully vested.
F5 These options were granted on 02/21/2017. These options are fully vested.
F6 These options were granted on 4/28/2016. These options are fully vested.
F7 These options were granted on 2/22/2022. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.

Remarks:

The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split.